Related Experiment Videos
Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons
Y Yamashita1, K Koike, M Takaoki
1Central Research Division, Takeda Chemical Industries, Ltd., Osaka.
Abstract:
Recombinant human interferon alpha 2a as well as natural human interferons alpha and beta significantly suppressed the production of hepatitis B surface antigen by PLC/PRF/5 cells (which have been established from a human primary hepatocellular carcinoma and proven to carry the hepatitis B virus DNA) and inhibited proliferation of these cells in vitro. However, the production of alpha-fetoprotein by PLC/PRF/5 cells was less significantly affected by any of the interferons. These results suggest that these interferons not only suppress cellular proliferation but also selectively inhibit the action of the HBV gene which is persistently present in these cells.
Insights
Human interferons (IFNs) effectively suppressed hepatitis B surface antigen production and cell proliferation in liver cancer cells. IFNs also selectively inhibited the hepatitis B virus (HBV) gene, suggesting therapeutic potential.
Area of Science:
- Hepatology
- Virology
- Immunology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern, often linked to chronic hepatitis B virus (HBV) infection.
- Interferons (IFNs) are cytokines with known antiviral and antiproliferative properties.
- The persistent presence of HBV DNA in HCC cells like PLC/PRF/5 presents a challenge for treatment.
Purpose of the Study:
- To investigate the effect of recombinant human interferon alpha 2a and natural human interferons alpha and beta on HBV replication and liver cancer cell behavior.
- To determine the impact of these interferons on hepatitis B surface antigen (HBsAg) production, alpha-fetoprotein (AFP) levels, and cell proliferation in PLC/PRF/5 cells.
Main Methods:
- Treatment of PLC/PRF/5 cells (derived from human HCC carrying HBV DNA) with recombinant human interferon alpha 2a, natural human interferon alpha, and natural human interferon beta.
- In vitro assays to measure hepatitis B surface antigen production, alpha-fetoprotein levels, and cell proliferation.
Main Results:
- Significant suppression of hepatitis B surface antigen production by all tested interferons.
- Inhibition of proliferation in PLC/PRF/5 cells treated with interferons.
- Minimal impact on alpha-fetoprotein production by the interferons.
Conclusions:
- Human interferons demonstrate potent antiviral activity against HBV by suppressing HBsAg production.
- Interferons exhibit antiproliferative effects on HBV-infected liver cancer cells.
- These findings suggest that interferons can selectively inhibit the action of the persistently present HBV gene, offering potential therapeutic strategies for HCC.